Turkey expands reach in pharma market biopharm international. While the turkish pharmaceutical sector is ranked 16th in terms of market value, it is 36th in terms of the clinical research conducted and the volume of pharmaceutical exports. The value of the pharmaceutical market in turkey has increased significantly since. For these reasons, in this study the market concentration ratios of the pharmaceutical sector in turkey are calculated by using concentration.
Low levels of healthcare insurance penetration mean that pharma sales are predominantly driven by outofpocket expenditure. Union that is, the member states, the different parts of the pharmaceutical industry, including the researchbased industry, the generic manufacturers as well as parallel importers, wholesalers and, last but not least, health care providers and health insurance bodies, and patients. General information on turkey w ith a yearly growth rate of 9. Pharmaceutical manufacturers association of turkey. Pharmaceuticals in turkey report is published on march 12, 2019 and has 37 pages in it. However, this takes place amid a reduced growth in sales and production, forcing market players to look for new growth opportunities. The turkish pharmaceutical industry has a longstanding culture of production as well as a strong infrastructure. This paper reflects the situation in the pharmaceutical sector in turkey, identifies critical issues, and discusses policy options based on current trends and the overall policy objectives of. After gathering views from our clients and stakeholders in istanbul, we share a general view about digital engagement of pharma marketing in turkey the health status of people in turkey has significantly improved in recent years. The pharmaceutical market in turkey is poised for strong expansion. Pharma intelligence 2 turkish pharmaceutical market turkey is a key emerging market for pharmaceutical companies despite its many challenges ranked as the 16th largest pharmaceutical market in the world and the seventh biggest in europe in 2011 in terms of sales, turkeys domestic market offers many opportunities. We assist pharmaceutical, biotech, medical device and other life science companies to register their products and access the diverse and rapidly growing markets throughout australia, new zealand and asia singapore, malaysia, indonesia, thailand, the philippines, vietnam, brunei, china.
Global pharmaceuticals industry analysis and trends 2023. Turkey pharmaceuticals 2015 is a work of seminal importance both in the insight it provides as to the many benefits of pharmaceutical manufacturing within turkey and the context it grants to the develop ment of turkeys manufacturing sector, but, moreover, for its symbolic significance. Transformations in disease treatment the number of new medicines reaching patients will be historically large with 2,240 drugs in the. Chart 26 pharmaceutical industry within turkish foreign trade. Turkish pharmaceutical market turkey is a key emerging market for pharmaceutical companies despite its many challenges ranked as the 16th largest pharmaceutical market in the world and the seventh biggest in europe in 2011 in terms of sales, turkey s domestic market offers many opportunities. The russian pharmaceutical market continues to see growth, including an increase in sales seen in ruble terms. The report is an analysis of the pharma market across turkey, including all major turkish manufacturers, as well as an evaluation of conditions for both foreign and domestic companies. Overview of turkeys pharmaceuticals market the turkish pharmaceutical market is the 16th largest in the world and the 7th largest in europe. An analysis of export markets indicates that in 2010 there were exports to a total of. The companys latest report states that turkeys pharmaceutical market has changed extensively over the past decade due to the health transformation program introduced by the government in 2003 and has become one of the countrys most. Turkey healthcare, pharma and devices analysis and data. Russian pharmaceutical market trends in 2018 deloitte.
The analysis of the turkish pharma market was conducted among all major turkish manufacturers, evaluating conditions for both foreign and domestic companies. Pwc turkey has issued the turkeys pharmaceutical sector vision 2023 report for the association of researchbased pharmaceutical companies. Government policies that would be implemented in pricing and reimbursement processes may result positive effects to access of medicines in the short term and in the long term, but in order to prevent drug shortages and access to therapies turkish. In 2018, the turkish pharmaceuticals market grew in value by 26. In 2018, the pharmaceutical market in turkey had a total sales value of approximately 31 billion turkish lira. Turkey healthcare, pharma and devices analysis, data forecasts from the eiu to support industry executives decisionmaking. This study offers a comprehensive, 360 degree analysis on the saudi arabia pharmaceutical market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges.
The domestic market for turkey s pharmaceuticals industry is defined by challenging factors both in terms of pricing restrictions and instability in the political and economic landscape, but the demographic makeup of the country, together with increasing governmental industry support, is counteracting these unfavorable conditions. The reference pharmaceutical market completed 2018 with a value of tl 21. Turkish pharmaceutical industry globally available. Global pharmaceuticals market is expected to be worth usd 1. Comparison of pharmaceutical pricing and reimbursement. While the turkish pharmaceutical sector is ranked 16th in terms of market value, it is. The report contains analyses of countries with successful pharma sectors as well as suggestions for roadmaps, basic strategies and policies alongside concrete, applicable steps for implementation. Pharmaceutical consumption aalimentary tract and metabolism a02aantacids a02bdrugs for peptic ulcer and gastrooesophageal reflux diseases gord a10drugs used in diabetes bblood and blood forming organs ccardiovascular system c01acardiac glycosides c01bantiarrhythmics, class i and iii c02antihypertensives c03diuretics c07beta. An incisive, indepth analysis on the saudi arabia pharmaceutical market. Pharmaceutical market saudi arabia industry analysis. Biosimilar drug market increased by 121,6% and reached 624,4 million tl.
Chart 1 turkish pharmaceutical market chart 1 an analysis of the 9year period between 2010 and 2018 indicates that the pharmaceutical market grew by 1% to 30. Chapter six makes the analysis of pharmaceutical consumption, pharmaceutical market and pricing in turkey and compares these three with oecd countries. Rajesh chhabara reports on how turkeys future pharma growth depends on reform and european union membership with a population of 73 million, turkey accounts for 40% of the middle eastern pharmaceutical market. The following article is shifted towards the current landscape of sales and marketing within pharmaceutical industry of turkey. Global giant novartis is number one in a market worth a total of more than seven billion dollars. Thus, any pharmaceutical product imported into turkey should be registered in the name of the turkish agent or a turkish commercial entity. This growth signifies a compound annual growth rate cagr of 11%, which. The intersection of these regulatory and market pathways. Pharmaceutical market access in turkey a regulatory. According to the report, the pharmaceutical industry in turkey increased by 8. Global healthcare trends and outlook medicines for europe. Pharma marketing trends in turkey welcome to aqurance. Turkey pharmaceuticals 2015 is a work of seminal importance both in the insight it provides as to the many benefits of pharmaceutical manufacturing within turkey and the context it grants to the develop ment of turkey s manufacturing sector, but, moreover, for its symbolic significance.
In 2009, the total audited pharmaceutical market for turkey grew by 15. The following is a list of the top 100 pharma companies in turkey sorted by total value of sales in usd for 2014. The president is elected by citizens for a five year term 1. Interview with titck turkish medicines and medical devices agency 15. Further, incidence of chronic conditions in the developing world will increasingly resemble those of the. Pdf market structure of the turkish pharmaceutical industry. Biotechnological products constituted 17,2% of prescription drugs with 7 billion tl and 29,4 million units in 2019. Turkey now supports a price efficient manufacturing industry far cheaper than those in the west and with comparable regulatory standards, concludes a pharma insights report from cphi worldwide and global business reports. Turkey is an important market for pharmaceutical sector with a population of over 75 million. Turkey, a rising star in the region and the world, has ambitious social. Turkeys pharmaceutical sector vision 2023 report overview. Turkey syria, turkey, lebanon, iraq europe impact refugee crisis terrorism nigeria, pakistan, india, egypt, turkey global impact.
The industry complies with todays international standards in terms of its production technologies, capacity and qualified human resources. In turkey, the pharmaceutical market reached tl 30. Growth rates of 20% and more per annum were observed in the period between 2002 and 2005, making turkey one of the hottest markets for pharmaceuticals worldwide. A growing pharma market with huge potential pmlive. Turkeys pharma market is ripe for profitability pmlive. It was valued at 5 billion usd in 2015 which registered a cagr of 9% in the last 10 years, amplified by expanded public insurance, modernisation, broad prevalence of chronic diseases, and increased. Sens pharma pharmaceuticals wholesale info email web phone adana sehitler tepesi mah. A growing pharma market with huge potential the turkish biopharma market offers many opportunities if it can overcome its sustainability challenge waiting in line, trying to decipher the different languages spoken around you. Rapid growth is being driven by the to continue reading the pharma letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, roundups and commentary from the sharpest minds in the pharmaceutical and biotechnology space. Transforming the turkish pharma market eyeforpharma. With a growing global healthcare burden, global pharmaceutical market growth is expected to show a cagr of 4. It will help you make lucrative business decision as it contains swot analysis, company profiling, business strategies of market players and their. Pharma to market is a leading regulatory affairs consulting company operating in the asiapacific region.
The grand national assembly has 550 members elected for four years term, by secret ballot. According to turkey pharmaceutical market janjune 2017 report, pharmaceutical manufacturers association of turkey, pharmaceutical sales in hospitals and pharmacies have increased by %16 and reached 11,9 billion tl. Sectoral overview 2019 pharmaceutical market turkey. The us is almost half of the world pharmaceutical market. An outlook on biotech pharmaceuticals market in turkey. The reference biotechnological pharmaceutical market grew by 23,6% to total 6,4 billion tl. Positive list discounts for reimbursement status drugs are categorized by equivalency groups based on active substance. Pharmaceutical market value in turkey 20102018 statista. The executive branch is the government, headed by the prime minister.
664 1563 1249 1098 1244 546 1378 792 1349 298 146 509 135 1319 536 1614 404 211 238 406 289 1345 313 1095 965 849 1525 1509 544 1201 706 1214 1154 1143 545 1175 1195 1381 1240